XML 129 R56.htm IDEA: XBRL DOCUMENT v3.25.1

Reportable segments (Tables)

12 Months Ended

Dec. 31, 2024

Disclosure of operating segments [abstract]

Schedule of reportable segments

Operating segment items for the year ended December 31, 2024						Specialty plant nutrients						Iodine and its derivatives						Lithium and its derivatives						Industrial chemicals						Potassium						Other products and services						Reportable segments						Operating segments						Unallocated amounts						Total as of December 31, 2024
						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$
Revenue						941,940						968,312						2,241,250						78,155						270,783						28,321						4,528,761						4,528,761						—						4,528,761
Revenues from transactions with other operating segments of the same entity						—						—						—						—						—						—						—						—						—						—
Revenues from external customers and transactions with other operating segments of the same entity						941,940						968,312						2,241,250						78,155						270,783						28,321						4,528,761						4,528,761						—						4,528,761
Costs of sales						(775,152)						(444,904)						(1,666,328)						(47,453)						(236,390)						(31,427)						(3,201,654)						(3,201,654)						—						(3,201,654)
Administrative expenses						—						—						—						—						—						—						—						—						(185,959)						(185,959)
Finance expense						—						—						—						—						—						—						—						—						(197,544)						(197,544)
Depreciation and amortization expense						(72,211)						(57,038)						(187,538)						(6,328)						(19,275)						(34)						(342,424)						(342,424)						—						(342,424)
The entity’s interest in the income of associates and joint ventures accounted for by the equity method						—						—						—						—						—						—						—						—						11,025						11,025
Income before taxes						166,788						523,408						574,922						30,702						34,393						(3,106)						1,327,107						1,327,107						(352,693)						974,414
Income tax expense						—						—						—						—						—						—						—						—						(282,573)						(282,573)
Net income (loss)						166,788						523,408						574,922						30,702						34,393						(3,106)						1,327,107						1,327,107						(635,266)						691,841
Assets						—						—						—						—						—						—						—						—						11,495,569						11,495,569
Equity-accounted investees						—						—						—						—						—						—						—						—						585,794						585,794
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts						—						—						—						—						—						—						—						—						(1,181,113)						(1,181,113)
Liabilities						—						—						—						—						—						—						—						—						6,297,502						6,297,502
Impairment loss of financial assets recognized in income																																										—						—						(639)						(639)
Impairment loss of non-financial assets recognized in income						—						—						—						—						—						—						—						—						(7,134)						(7,134)
Cash flows
Cash flows from operating activities						—						—						—						—						—						—						—						—						1,274,678						1,274,678
Cash flows used in investing activities						—						—						—						—						—						—						—						—						(1,213,992)						(1,213,992)
Cash flows from financing activities						—						—						—						—						—						—						—						—						282,383						282,383

Operating segment items for the year ended December 31, 2023						Specialty plant nutrients						Iodine and its derivatives						Lithium and its derivatives						Industrial chemicals						Potassium						Other products and services						Reportable segments						Operating segments						Unallocated amounts						Total as of December 31, 2023
						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$
Revenue						913,912						892,151						5,180,114						175,223						279,050						27,040						7,467,490						7,467,490						—						7,467,490
Revenues from transactions with other operating segments of the same entity						—						—						—						—						—						—						—						—						—						—
Revenues from external customers and transactions with other operating segments of the same entity						913,912						892,151						5,180,114						175,223						279,050						27,040						7,467,490						7,467,490						—						7,467,490
Costs of sales						(691,509)						(355,717)						(2,955,669)						(141,351)						(219,597)						(28,593)						(4,392,436)						(4,392,436)						—						(4,392,436)
Administrative expenses						—						—						—						—						—						—						—						—						(175,765)						(175,765)
Finance expense						—						—						—						—						—						—						—						—						(138,402)						(138,402)
Depreciation and amortization expense						(70,342)						(53,140)						(124,010)						(15,232)						(18,006)						(57)						(280,787)						(280,787)						—						(280,787)
The entity’s interest in the income of associates and joint ventures accounted for by the equity method						—						—						—						—						—						—						—						—						593						593
Income before taxes						222,403						536,434						2,224,445						33,872						59,453						(1,553)						3,075,054						3,075,054						(268,036)						2,807,018
Income tax expense						—						—						—						—						—						—						—						—						(1,876,751)						(1,876,751)
Net income (loss)						222,403						536,434						2,224,445						33,872						59,453						(1,553)						3,075,054						3,075,054						(2,144,787)						930,267
Assets						—						—						—						—						—						—						—						—						10,778,837						10,778,837
Equity-accounted investees						—						—						—						—						—						—						—						—						86,417						86,417
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts						—						—						—						—						—						—						—						—						2,785,385						2,785,385
Liabilities						—						—						—						—						—						—						—						—						6,301,408						6,301,408
Impairment loss of financial assets recognized in income																																										—						—						202						202
Impairment loss of non-financial assets recognized in income						—						—						—						—						—						—						—						—						(47,068)						(47,068)
Cash flows
Cash flows from operating activities						—						—						—						—						—						—						—						—						(196,639)						(196,639)
Cash flows used in investing activities						—						—						—						—						—						—						—						—						(1,481,493)						(1,481,493)
Cash flows from financing activities						—						—						—						—						—						—						—						—						66,261						66,261

Operating segment items for the year ended December 31, 2022						Specialty plant nutrients						Iodine and its derivatives						Lithium and its derivatives						Industrial chemicals						Potassium						Other products and services						Reportable segments						Operating segments						Unallocated amounts						Total as of December 31, 2022
						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$
Revenue						1,172,334						754,339						8,152,939						165,200						437,180						28,586						10,710,578						10,710,578						—						10,710,578
Revenues from transactions with other operating segments of the same entity						—						—						—						—						—						—						—						—						—						—
Revenues from external customers and transactions with other operating segments of the same entity						1,172,334						754,339						8,152,939						165,200						437,180						28,586						10,710,578						10,710,578						—						10,710,578
Costs of sales						(722,261)						(282,100)						(3,636,852)						(112,247)						(193,581)						(26,912)						(4,973,953)						(4,973,953)						—						(4,973,953)
Administrative expenses						—						—						—						—						—						—						—						—						(142,644)						(142,644)
Finance expense						—						—						—						—						—						—						—						—						(86,651)						(86,651)
Depreciation and amortization expense						(63,321)						(53,734)						(88,510)						(14,724)						(24,043)						(126)						(244,458)						(244,458)						—						(244,458)
The entity’s interest in the income of associates and joint ventures accounted for by the equity method						—						—						—						—						—						—						—						—						20,159						20,159
Income before taxes						450,073						472,239						4,516,087						52,953						243,599						1,674						5,736,625						5,736,625						(250,129)						5,486,496
Income tax expense						—						—						—						—						—						—						—						—						(1,572,212)						(1,572,212)
Net income (loss)						450,073						472,239						4,516,087						52,953						243,599						1,674						5,736,625						5,736,625						(1,822,341)						3,914,284
Assets						—						—						—						—						—						—						—						—						10,819,101						10,819,101
Equity-accounted investees						—						—						—						—						—						—						—						—						54,386						54,386
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts						—						—						—						—						—						—						—						—						1,757,581						1,757,581
Other Liabilities						—						—						—						—						—						—						—						—						5,887,100						5,887,100
Impairment loss of financial assets recognized in income																																										—						—						3,369						3,369
Impairment loss of non-financial assets recognized in income						—						—						—						—						—						—						—						—						(42,233)						(42,233)
Cash flows
Cash flows from operating activities						—						—						—						—						—						—						—						—						4,077,595						4,077,595
Cash flows used in investing activities						—						—						—						—						—						—						—						—						(909,401)						(909,401)
Cash flows from financing activities						—						—						—						—						—						—						—						—						(2,002,969)						(2,002,969)

Items in the statement of comprehensive income for the year ended December 31,2024						Specialty plant nutrients						Iodine and its derivatives						Lithium and its derivatives						Industrial chemicals						Potassium						Other products and services						Corporate Unit						Total segments and Corporate unit
						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$
Revenue						941,940						968,312						2,241,250						78,155						270,783						28,321						—						4,528,761
Costs of sales						(775,152)						(444,904)						(1,666,328)						(47,453)						(236,390)						(31,427)						—						(3,201,654)
Gross profit						166,788						523,408						574,922						30,702						34,393						(3,106)						—						1,327,107
Other incomes by function						—						—						—						—						—						—						32,229						32,229
Administrative expenses						—						—						—						—						—						—						(185,959)						(185,959)
Other expenses by function						—						—						—						—						—						—						(104,698)						(104,698)
Impairment of gains and review of impairment losses (impairment losses) determined in accordance with IFRS 9						—						—						—						—						—						—						(639)						(639)
Other losses						—						—						—						—						—						—						(2,142)						(2,142)
Financial income						—						—						—						—						—						—						103,642						103,642
Financial costs						—						—						—						—						—						—						(197,544)						(197,544)
Interest in the income of associates and joint ventures accounted for by the equity method						—						—						—						—						—						—						11,025						11,025
Exchange differences						—						—						—						—						—						—						(8,607)						(8,607)
Income before taxes						166,788						523,408						574,922						30,702						34,393						(3,106)						(352,693)						974,414
Income tax expense						—						—						—						—						—						—						(282,573)						(282,573)
Net income						166,788						523,408						574,922						30,702						34,393						(3,106)						(635,266)						691,841

Items in the statement of comprehensive income for the year ended December 31,2023						Specialty plant nutrients						Iodine and its derivatives						Lithium and its derivatives						Industrial chemicals						Potassium						Other products and services						Corporate Unit						Total segments and Corporate unit
						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$
Revenue						913,912						892,151						5,180,114						175,223						279,050						27,040						—						7,467,490
Costs of sales						(691,509)						(355,717)						(2,955,669)						(141,351)						(219,597)						(28,593)						—						(4,392,436)
Gross profit						222,403						536,434						2,224,445						33,872						59,453						(1,553)						—						3,075,054
Other incomes by function						—						—						—						—						—						—						40,557						40,557
Administrative expenses						—						—						—						—						—						—						(175,765)						(175,765)
Other expenses by function						—						—						—						—						—						—						(93,400)						(93,400)
Impairment of gains and review of impairment losses (impairment losses) determined in accordance with IFRS 9						—						—						—						—						—						—						202						202
Other gains						—						—						—						—						—						—						(2,254)						(2,254)
Financial income						—						—						—						—						—						—						122,726						122,726
Financial costs						—						—						—						—						—						—						(138,402)						(138,402)
Interest in the income of associates and joint ventures accounted for by the equity method						—						—						—						—						—						—						593						593
Exchange differences						—						—						—						—						—						—						(22,293)						(22,293)
Income before taxes						222,403						536,434						2,224,445						33,872						59,453						(1,553)						(268,036)						2,807,018
Income tax expense						—						—						—						—						—						—						(1,876,751)						(1,876,751)
Net income						222,403						536,434						2,224,445						33,872						59,453						(1,553)						(2,144,787)						930,267

Items in the statement of comprehensive income for the year ended December 31,2022						Specialty plant nutrients						Iodine and its derivatives						Lithium and its derivatives						Industrial chemicals						Potassium						Other products and services						Corporate Unit						Total segments and Corporate unit
						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$
Revenue						1,172,334						754,339						8,152,939						165,200						437,180						28,586						—						10,710,578
Cost of sales						(722,261)						(282,100)						(3,636,852)						(112,247)						(193,581)						(26,912)						—						(4,973,953)
Gross profit						450,073						472,239						4,516,087						52,953						243,599						1,674						—						5,736,625
Other incomes by function						—						—						—						—						—						—						9,854						9,854
Administrative expenses						—						—						—						—						—						—						(142,644)						(142,644)
Other expenses by function						—						—						—						—						—						—						(75,971)						(75,971)
Impairment of gains and review of impairment losses (impairment losses) determined in accordance with IFRS 9						—						—						—						—						—						—						3,369						3,369
Other losses						—						—						—						—						—						—						117						117
Financial income						—						—						—						—						—						—						47,038						47,038
Financial costs						—						—						—						—						—						—						(86,651)						(86,651)
Interest in the income of associates and joint ventures accounted for by the equity method						—						—						—						—						—						—						20,159						20,159
Exchange differences						—						—						—						—						—						—						(25,400)						(25,400)
Income before taxes						450,073						472,239						4,516,087						52,953						243,599						1,674						(250,129)						5,486,496
Income tax expense						—						—						—						—						—						—						(1,572,212)						(1,572,212)
Net income from continuing operations						450,073						472,239						4,516,087						52,953						243,599						1,674						(1,822,341)						3,914,284

Schedule of geographical areas

Segments by geographical areas						Chile						Latin America and the Caribbean						Europe						North America						Asia and others						Total
						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$
Revenue at December 31, 2024						171,551						240,629						681,607						689,794						2,745,180						4,528,761
Non-current assets at December 31, 2024
Investment accounted for under the equity method						—						—						13,912						17,470						554,412						585,794
Intangible assets other than goodwill						73,762						450						6,466						547						86,743						167,968
Goodwill						—						86						138						724						—						948
Property, plant and equipment, net						3,465,971						6,651						10,598						8,277						942,148						4,433,645
Right-of-use assets						46,122						1,806						3,234						6,112						26,796						84,070
Other non-current assets						68,777						29						—						5,413						289,947						364,166
Non-current assets						3,654,632						9,022						34,348						38,543						1,900,046						5,636,591

Segments by geographical areas						Chile						Latin America and the Caribbean						Europe						North America						Asia and others						Total
						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$
Revenue for the year ended December 31, 2023						169,681						210,299						828,112						783,611						5,475,787						7,467,490
Non-current assets at December 31, 2023
Investment accounted for under the equity method						—						22,490						42,726						17,657						3,544						86,417
Intangible assets other than goodwill						67,671						360						6,440						876						80,527						155,874
Goodwill						—						86						148						724						—						958
Property, plant and equipment, net						2,888,778						776						14,485						6,322						699,576						3,609,937
Right-of-use assets						32,359						19						3,716						8,619						28,480						73,193
Other non-current assets						60,363						18						—						5,099						308,220						373,700
Non-current assets						3,049,171						23,749						67,515						39,297						1,120,347						4,300,079

Segments by geographical areas						Chile						Latin America and the Caribbean						Europe						North America						Asia and others						Total
						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$						ThUS$
Revenue for the year ended December 31, 2022						223,148						339,940						932,558						914,187						8,300,745						10,710,578
Non-current assets at December 31, 2022
Investment accounted for under the equity method						—						20,792						15,939						17,655						—						54,386
Intangible assets other than goodwill						75,666						428						6,497						1,345						82,400						166,336
Goodwill						—						86						158						723						—						967
Property, plant and equipment, net						2,269,923						743						14,978						4,506						436,688						2,726,838
Right-of-use assets						32,312						47						1,651						2,739						24,118						60,867
Other non-current assets						46,640						17						6						4,706						1,027						52,396
Non-current assets						2,424,541						22,113						39,229						31,674						544,233						3,061,790

X

- Definition

The entire disclosure for operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2024-01-01
-Section Disclosure
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of geographical information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2024-01-01
-Paragraph 33
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_33&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_DisclosureOfGeographicalAreasExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfOperatingSegmentsAbstract
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration